Ignite Creation Date:
2024-05-06 @ 4:09 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04888364
Status:
UNKNOWN
Last Update Posted:
2021-08-26
First Post:
2021-04-19
Brief Title:
French Parkinsons Disease Cohort - NS-PARK
Sponsor:
Institut National de la Santé Et de la Recherche Médicale France
Organization:
Institut National de la Santé Et de la Recherche Médicale France
Study Overview
Official Title:
Cohort of the French Clinical Research Network for Parkinsons Disease NS-PARK Cohort
Status:
UNKNOWN
Status Verified Date:
2021-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NS-PARK
Brief Summary:
The aim of NS-PARK cohort are to describe the natural history of Parkinsons disease PD and to propose patients stratification models based on PD pathophysiological mechanisms Patients are included at all PD expert centers in France Standardized demographic diagnosis motor and non-motor symptoms evaluation and treatment information are collected and clinical data are updated at each visit of the patient at the center A blood sampling is perform at baseline for genetic testing and implement an associated biocollection
Detailed Description:
The national clinical research network for Parkinsons disease NS-PARKFCRIN reassembles all expert centers in Parkinsons disease PD in France Its aim is to promote clinical research in Parkinsons disease and movement disorder to better understand the pathophysiology of PD foster the development of new therapeutic strategies and move towards personalized medicine To help centers for prescreening a national registry of PD patients followed in each centers has been implemented in 2016 to collect minimal relevant clinical information of patients followed in each center including demographic data age at diagnosis standardized motor and non-motor symptoms evaluation and treatment Data are updated at each visit of the patient in the center De facto this registry became a longitudinal cohort of PD patients followed in NS-PARK centers In 2020 NS-PARK received funding to associate a biocollection to this clinical cohort
The aim of NS-PARK cohort are to describe the natural history of PD progression in clinical routine in France to develop new models of PD describing the different progression profiles and to propose patients stratification based on PD pathophysiological mechanisms The cohort will also serve as a platform to discover new PD genes and genetic modifiers of disease progression or response to treatment
The aim of NS-PARK cohort are to describe the natural history of PD progression in clinical routine in France to develop new models of PD describing the different progression profiles and to propose patients stratification based on PD pathophysiological mechanisms The cohort will also serve as a platform to discover new PD genes and genetic modifiers of disease progression or response to treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2019-A01929-48 | REGISTRY | RCB ID | None |